Navigation Links
Can Eating Peppers Lower the Risk of Parkinson’s Disease?
Date:7/23/2013

Sturgeon Bay, WI (PRWEB) July 23, 2013

Nearly 1 million Americans suffer from Parkinson’s disease, with over 50,000 new cases diagnosed yearly according to the National Parkinson Foundation. Parkinson’s is a degenerative disease affecting the brain, and is characterized by muscular tremors, stiffness affecting the arms, legs, and trunk; slow movements, and balance problems. Researchers have noted a decreased risk of developing Parkinson’s among smokers and other users of tobacco. Sturgeon Bay, Wisconsin Chiropractor and Naturopath Dr. J G Moellendorf, DC, ND, LCP questions whether nicotine or some other chemical could provide some type of protection against Parkinson’s.

A research team led by Dr. Susan Searles Nielsen of the University of Washington—Seattle, looked into this question by testing whether eating peppers, tomatoes, and potatoes, which are in the same plant family Solanaceae as tobacco, would lower the risk of developing Parkinson’s.

A group of 490 patients newly diagnosed with Parkinson’s disease of unknown origin during 1992 to 2008, was compared to 644 neurologically normal patients. The patient’s self-reported consumption of peppers, tomatoes, tomato juice, and potatoes (Solanaceae vegetables) was examined to determine if there were any differences in the development of Parkinson’s. The consumption of Solanaceae vegetables was then adjusted for the consumption of other vegetables, tobacco and caffeine use, age, sex, and ethnic background.

It was found that the consumption of all of the Solanaceae vegetables combined decreased the risk of developing Parkinson’s by 19% compared to all other vegetables com
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. UCLA team develops highly efficient method for creating flexible, transparent electrodes
2. Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany
3. Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy
4. Stem Cell Therapy Shown to be Effective in Treating Liver Cirrhosis
5. Chemical makes blind mice see; compound holds promise for treating humans
6. Lightlake Therapeutics Inc. Announces Positive Final Phase II Clinical Trial Results of Binge Eating Disorder Treatment
7. Trudeau Institute Awarded Grant to Investigate a New Approach to Treating Illnesses Caused by Weaponized and Antibiotic-Resistant Bacteria
8. BioFit Helps Lab Specifiers Resolve to Improve Worker Safety and Productivity in 2013 through Ergonomic Seating Use
9. Are Pros "Cheating" with Undetectable HGH Boosters?
10. Texas Fertility Center ‘March Dadness’ Campaign Focuses on the Odds of Beating Male Infertility
11. Treating Back Pain in Baby Boomers Threatens to Bankrupt the Healthcare System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)...  Pharmacyclics, Inc. (NASDAQ: PCYC ) ... newly developed Bruton,s tyrosine kinase (BTK) inhibitor for ... results of these preclinical evaluations have been communicated ... feedback received from the Agency is supportive of ... preclinical work is required to begin a Phase ...
(Date:2/27/2015)... Bionomics Limited (ASX:BNO, ADR:BMICY) is to present ... in patients with metastatic renal cancer at the ASCO ... . The data will be presented by Dr. ... Cancer Center in California in ... identifies Ferritin and IL-8 as two baseline biomarkers that ...
(Date:2/27/2015)... Feb. 27, 2015   PureTech , a science ... commercializing disruptive products and technologies in the healthcare sector, ... former CEO and Member of the Board of Directors ... "It,s has been a pleasure to know Chris ... we will be working together more closely now," said ...
(Date:2/26/2015)... Feb. 26, 2015   Synageva BioPharma Corp. ... company developing therapeutic products for rare disorders, today ... 2015 goals, other key objectives, and financial guidance.  ... today at 4:30 p.m. EST to review the ... To participate in today,s call by telephone, please ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9
... LONDON, June 26, 2011 The pharmaceutical industry spent less on ... three years, according to data released today from the 2011 ... Thomson Reuters business. Key highlights from the ... new molecular entities (NMEs) were launched on the global market in ...
... 2011 Cebix Incorporated announced today that preclinical data ... (CBX129801), demonstrated a half-life of three days as compared ... impairment in nerve conduction velocity, a measure of the ... in an animal model of diabetic peripheral neuropathy. Additionally, ...
... Netherlands, June 24, 2011 /PRNewswire-iReach/ -- ...  announced today the completion of a non-exclusive research ... ("Lilly"), a global pharmaceutical company, to generate and ... light chains(H2L2) using one of Harbour,s transgenic mouse ...
Cached Biology Technology:Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International 2Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International 3Cebix's Long-Acting C-Peptide Ersatta™ has Potential in Multiple Chronic Complications of Diabetes 2Cebix's Long-Acting C-Peptide Ersatta™ has Potential in Multiple Chronic Complications of Diabetes 3Harbour Antibodies BV Signs Research and Licence Agreement With Lilly 2
(Date:2/5/2015)... 26, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... http://www.nxt-id.com/ ) as part of its 2015 marketing and ... launched its new consumer website for Wocketwallet.com earlier this ... of NXT-ID said, "Our new corporate website naturally showcases ...
(Date:2/5/2015)... Jan. 28, 2015 Research and Markets ... of the "Global Biometrics Market (2014-2020): Market ... Countries " report to their offering. , ... Asia-Pacific is anticipated to overtake ... to increasing government spending towards IT security, government ...
(Date:1/22/2015)... CHICAGO , Jan. 9, 2015 Valid S.A. ("Company") ... the market in general the State of Washington,s ... contract for a new enrollment and central issuance system for ... The project planning and development will start ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Valid USA Signs Contract For Washington Driver's License Issuance 2
... The next big thing in medical diagnostics could ... the material from which sand is formed, silicon dioxide. ... 230 nanometers across, can be used to trap antibodies ... the bacteria that causes potentially lethal diarrhea. According ...
... current check for kidney disease is a simple blood test ... days for this metabolite to accumulate to levels that are ... it may be too late to intervene. To close ... scientists and physicians led by Dr. Jonathan Barasch, M.D., Ph.D., ...
... few better-known proteins than nestin, whose very presence in an ... a neural stem cell. As helpful as this is to ... in a cell. In a study published in the ... , Salk Institute of Biological Studies investigators led by Kuo-Fen ...
Cached Biology News:Detecting lethal diseases with rust and sand 2Seeing kidney injury, as it happens 2Salk researchers discover that stem cell marker regulates synapse formation 2Salk researchers discover that stem cell marker regulates synapse formation 3
Collected from sexually mature, mixed sex, mixed breed guinea pigs. Pricing: $120/unit for 1 - 10 units...
SEQUENASE PCR PRODUCT PRE-SEQU, 1 EA. Category: SEQUENASE....
Mouse monoclonal [IFR0104] to Salmonella enteriditis ( Abpromise for all tested applications)....
All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units...
Biology Products: